Influence of intravenously administered lipids on reticuloendotelial function.
D000818:Animals; D005227:Fatty Acids / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008264:Macrophages / Q000378:metabolism; D008297:Male; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000187:drug effects* / Q000502:physiology*; D009929:Organ Size; D010169:Palmitic Acids / Q000378:metabolism; D010587:Phagocytosis; D010713:Phosphatidylcholines / Q000494:pharmacology*; D010714:Phosphatidylethanolamines / Q000494:pharmacology*; D013109:Sphingomyelins / Q000494:pharmacology*; D013154:Spleen / Q000187:drug effects; D013501:Surface-Active Agents / Q000494:pharmacology*
D005227:Fatty Acids; D010169:Palmitic Acids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D013109:Sphingomyelins; D013501:Surface-Active Agents